Quanterix Corporation Deferred Tax Assets, Deferred Income
Quanterix Corporation (QTRX) had Deferred Tax Assets, Deferred Income of $6.32 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2026-03-02
- 2025-12-31: Deferred Tax Assets, Deferred Income $6.32M.
- 2024-12-31: Deferred Tax Assets, Deferred Income $2.41M.
- 2023-12-31: Deferred Tax Assets, Deferred Income $2.57M; Deferred Tax Assets, Deferred Income as first filed $2.52M.
- 2022-12-31: Deferred Tax Assets, Deferred Income $2.38M.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2025-12-31 | $6.32M 10-K · filed 2026-03-02 | |
| 2024-12-31 | $2.41M 10-K · filed 2026-03-02 | |
| 2023-12-31 | $2.57M 10-K · filed 2025-03-17 | $2.52M 10-K · filed 2024-02-29 |
| 2022-12-31 | $2.38M 10-K/A · filed 2024-12-26 | |
| 2021-12-31 | $1.86M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $2.17M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $1.25M 10-K · filed 2021-03-05 | |
| 2018-12-31 | $1.61M 10-K · filed 2020-03-13 | |
| 2017-12-31 | $1.79M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |